Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.98 Billion USD | -59.08% |
| 2022 | 9.74 Billion USD | 4.44% |
| 2021 | 9.32 Billion USD | 10.18% |
| 2020 | 8.46 Billion USD | 30.67% |
| 2019 | 6.47 Billion USD | 37.28% |
| 2018 | 4.71 Billion USD | 14.1% |
| 2017 | 4.13 Billion USD | 6.57% |
| 2016 | 3.88 Billion USD | 52.51% |
| 2015 | 2.54 Billion USD | 26.29% |
| 2014 | 2.01 Billion USD | 57.52% |
| 2013 | 1.27 Billion USD | -27.89% |
| 2012 | 1.77 Billion USD | -1.11% |
| 2011 | 1.79 Billion USD | -0.46% |
| 2010 | 1.8 Billion USD | 25.5% |
| 2009 | 1.43 Billion USD | 13.48% |
| 2008 | 1.26 Billion USD | 29.58% |
| 2007 | 976.54 Million USD | 92.74% |
| 2006 | 506.67 Million USD | 135.92% |
| 2005 | 214.76 Million USD | -18.29% |
| 2004 | 262.83 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 5.3 Billion USD | -7.67% |
| 2023 Q1 | 13.1 Billion EUR | 4.6% |
| 2023 FY | 8.51 Billion EUR | -32.02% |
| 2023 Q3 | 8.51 Billion EUR | -35.0% |
| 2023 Q2 | 10.7 Billion USD | 9.89% |
| 2023 Q4 | 5.74 Billion USD | -46.37% |
| 2022 Q2 | 9.08 Billion USD | -2.62% |
| 2022 FY | 12.52 Billion EUR | 12.1% |
| 2022 Q4 | 9.74 Billion USD | 7.24% |
| 2022 Q1 | 11.57 Billion EUR | 3.62% |
| 2022 Q3 | 12.52 Billion EUR | 5.27% |
| 2021 Q2 | 9 Billion USD | 6.35% |
| 2021 Q4 | 9.32 Billion USD | 3.6% |
| 2021 Q3 | 11.29 Billion EUR | 9.27% |
| 2021 FY | 11.17 Billion EUR | 15.92% |
| 2021 Q1 | 10.1 Billion EUR | 4.8% |
| 2020 Q4 | 8.46 Billion USD | 21.6% |
| 2020 FY | 9.64 Billion EUR | 19.98% |
| 2020 Q1 | 8.49 Billion EUR | 5.72% |
| 2020 Q2 | 6.96 Billion USD | 7.46% |
| 2020 Q3 | 9.61 Billion EUR | 12.78% |
| 2019 Q1 | 7.7 Billion EUR | 53.48% |
| 2019 Q2 | 6.37 Billion USD | 34.98% |
| 2019 FY | 8.03 Billion EUR | 60.0% |
| 2019 Q3 | 8.36 Billion EUR | 7.32% |
| 2019 Q4 | 6.47 Billion USD | 1.7% |
| 2018 Q2 | 4.59 Billion USD | 11.19% |
| 2018 Q3 | 5.1 Billion EUR | 6.0% |
| 2018 Q1 | 4.89 Billion EUR | 10.82% |
| 2018 FY | 5.02 Billion EUR | 13.8% |
| 2018 Q4 | 4.71 Billion USD | 2.62% |
| 2017 Q4 | 4.13 Billion USD | 4.36% |
| 2017 Q1 | 4.43 Billion EUR | 20.44% |
| 2017 FY | 4.41 Billion EUR | 19.91% |
| 2017 Q2 | 3.96 Billion USD | 27.82% |
| 2017 Q3 | 4.47 Billion EUR | 2.49% |
| 2016 Q3 | 3.76 Billion EUR | 16.66% |
| 2016 Q4 | 3.1 Billion USD | -3.89% |
| 2016 Q2 | 3.22 Billion EUR | 0.0% |
| 2016 FY | 3.67 Billion EUR | 22.08% |
| 2016 Q1 | 3.34 Billion EUR | 10.96% |
| 2015 Q1 | 2.59 Billion EUR | 19.23% |
| 2015 Q2 | 2.51 Billion EUR | -3.31% |
| 2015 Q3 | 3.1 Billion EUR | 23.48% |
| 2015 FY | 3.01 Billion EUR | 38.35% |
| 2015 Q4 | 3.01 Billion EUR | -2.81% |
| 2014 Q1 | 2.06 Billion EUR | 18.32% |
| 2014 FY | 2.17 Billion EUR | 25.07% |
| 2014 Q4 | 2.17 Billion EUR | -4.49% |
| 2014 Q3 | 2.28 Billion EUR | 15.83% |
| 2014 Q2 | 1.96 Billion EUR | -4.45% |
| 2013 Q1 | 1.93 Billion EUR | 6.68% |
| 2013 Q3 | 1.79 Billion EUR | -3.46% |
| 2013 Q4 | 1.74 Billion EUR | -3.2% |
| 2013 FY | 1.74 Billion EUR | -3.8% |
| 2013 Q2 | 1.86 Billion EUR | -3.51% |
| 2012 Q4 | 1.81 Billion EUR | 0.0% |
| 2012 FY | 1.81 Billion EUR | 11.93% |
| 2012 Q2 | 1.75 Billion EUR | 0.0% |
| 2011 FY | 1.61 Billion EUR | 36.86% |
| 2011 Q4 | 1.61 Billion EUR | 0.0% |
| 2011 Q2 | 1.36 Billion EUR | 0.0% |
| 2010 Q4 | 1.18 Billion EUR | 0.0% |
| 2010 FY | 1.18 Billion EUR | -9.25% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 Q2 | 1.01 Billion EUR | 0.0% |
| 2009 FY | 1.3 Billion EUR | 9.65% |
| 2009 Q4 | 1.3 Billion EUR | 0.0% |
| 2008 FY | 1.18 Billion EUR | 34.43% |
| 2007 FY | 883.75 Million EUR | 59.36% |
| 2006 FY | 554.57 Million EUR | 78.89% |
| 2005 FY | 310.01 Million EUR | 4.58% |
| 2004 FY | 296.44 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 849015.738% |
| Arem Pacific Corporation | 181.02 Thousand USD | -2202242.244% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 1996347.597% |
| BioCorRx Inc. | 5.56 Million USD | -71481.694% |
| Bionik Laboratories Corp. | 1.98 Million USD | -200751.115% |
| Banyan Corp. | 3.6 Million USD | -110441.115% |
| Clearday, Inc. | 44.86 Million USD | -8785.502% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 199737.255% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -374247367.778% |
| Empower Clinics Inc. | 2.29 Million USD | -173323.721% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | -17062.207% |
| Selectis Health, Inc. | 35.76 Million USD | -11048.015% |
| Ethema Health Corporation | 14.51 Million USD | -27367.278% |
| HealthLynked Corp. | 1.72 Million USD | -230812.24% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | -28803.377% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -437123.263% |
| Comjoyful International Company | -28.32 Thousand USD | 14073120.58% |
| Medical Facilities Corporation | 92.22 Million USD | -4223.0% |
| MedSmart Group Inc. | 659.56 Thousand USD | -604354.478% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -1501980.139% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 580813.039% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -216776.657% |
| PAO Group, Inc. | 639.37 Thousand USD | -623437.986% |
| Primemd Inc. | 4.54 Million USD | -87644.038% |
| Raffles Medical Group Ltd | -194.49 Million USD | 2149.82% |
| Ryman Healthcare Limited | 1.51 Billion USD | -163.928% |
| Stem Cell Authority, Ltd. | 15.00 USD | -26578306566.667% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -320604.839% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -491170.793% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 1046490.026% |
| Veltex Corporation | 2.17 Million USD | -182826.842% |
| World Financial Holding Group | 98.11 Thousand USD | -4063322.788% |
| Xcelerate Inc. | 1.18 Million USD | -336970.001% |